{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:51:55Z","timestamp":1793620315120,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68161"],"award-info":[{"award-number":["N01-HV-68161"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68162"],"award-info":[{"award-number":["N01-HV-68162"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68163"],"award-info":[{"award-number":["N01-HV-68163"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68164"],"award-info":[{"award-number":["N01-HV-68164"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL090957"],"award-info":[{"award-number":["R01 HL090957"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL089765"],"award-info":[{"award-number":["R01 HL089765"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["MO1-RR00425"],"award-info":[{"award-number":["MO1-RR00425"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1RR033176"],"award-info":[{"award-number":["UL1RR033176"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000124"],"award-info":[{"award-number":["UL1TR000124"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16SDG27260115"],"award-info":[{"award-number":["16SDG27260115"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gustavus and Louis Pfeiffer Research Foundation"},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","award":["CDRN-1501-26692"],"award-info":[{"award-number":["CDRN-1501-26692"]}],"id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ijcard.2018.09.081","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T03:07:22Z","timestamp":1537931242000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation\u2013Coronary Vascular Dysfunction ancillary study"],"prefix":"10.1016","volume":"276","author":[{"given":"Cecil A.","family":"Rambarat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Handberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Noel","family":"Bairey Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo B.","family":"Minissian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.J.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslee J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galen","family":"Cook-Wiens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Pepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.09.081_bb0005","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0020","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/01.CIR.0000130642.79868.B2","article-title":"Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"109","author":"Johnson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0025","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2005.10.022","article-title":"Ischemic heart disease in women","volume":"47","author":"Pepine","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.CIR.0000115525.92645.16","article-title":"Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"109","author":"von Mering","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0040","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.jacc.2015.08.876","article-title":"Emergence of nonobstructive coronary artery disease: a woman's problem and need for change in definition on angiography","volume":"66","author":"Pepine","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0045","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2011.03.007","article-title":"Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease","volume":"4","author":"Mehta","year":"2011","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0050","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCIMAGING.114.001714","article-title":"Diastolic dysfunction in women with signs and symptoms of ischemia in the absence of obstructive coronary artery disease: a hypothesis-generating study","volume":"7","author":"Nelson","year":"2014","journal-title":"Circ. Cardiovasc. Imaging."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.106.103242","article-title":"Improved left ventricular function and reduced necrosis after myocardial ischemia\/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel","volume":"318","author":"Hale","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0065","first-page":"131","article-title":"Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem","volume":"20","author":"Cocco","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0070","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00877121","article-title":"Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease","volume":"8","author":"Hayashida","year":"1994","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0075","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/echo.12674","article-title":"Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease","volume":"32","author":"Tagliamonte","year":"2015","journal-title":"Echocardiography."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002481","article-title":"Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation","volume":"8","author":"Thomson","year":"2015","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0090","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0095","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.CIR.77.1.43","article-title":"Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test","volume":"77","author":"Nabel","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-12-42","article-title":"Reproducibility of adenosine stress cardiovascular magnetic resonance in multi-vessel symptomatic coronary artery disease","volume":"12","author":"Chih","year":"2010","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0110","first-page":"268","article-title":"Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software","volume":"2","author":"Goykhman","year":"2012","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0115","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ahj.2013.04.002","volume":"166","author":"Sharaf","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0125","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0130","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIRCULATIONAHA.105.597500","article-title":"Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions","volume":"113","author":"Chaitman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.081_bb0135","first-page":"R322","article-title":"Left ventricular diastolic dysfunction in women with nonobstructive ischemic heart disease: insights from magnetic resonance imaging and spectroscopy","volume":"313","author":"Nelson","year":"2017","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.arcmed.2012.11.002","article-title":"Effects of ranolazine on vasomotor responses of rat aortic rings","volume":"44","author":"Paredes-Carbajal","year":"2013","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.phrs.2011.06.018","article-title":"Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts","volume":"64","author":"Aldakkak","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0306-3623(97)00301-7","article-title":"Ranolazine: a novel metabolic modulator for the treatment of angina","volume":"30","author":"McCormack","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/clc.20935","article-title":"Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study","volume":"34","author":"Denardo","year":"2011","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0160","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005027","article-title":"Ranolazine in symptomatic diabetic patients without obstructive coronary artery disease: impact on microvascular and diastolic function","volume":"6","author":"Shah","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0170","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2007.08.060","article-title":"Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X","volume":"51","author":"Lanza","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11936-010-0083-8","article-title":"Treatment of angina and microvascular coronary dysfunction","volume":"12","author":"Samim","year":"2010","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2012.07.001","article-title":"Angina pectoris in women: focus on microvascular disease","volume":"163","author":"Zuchi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0185","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11886-014-0484-5","article-title":"CFR and FFR assessment with PET and CTA: strengths and limitations","volume":"16","author":"Nakazato","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.ijcard.2018.09.081_bb0190","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318339135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318339135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T11:31:14Z","timestamp":1546601474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318339135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"alternative-id":["S0167527318339135"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.081","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation\u2013Coronary Vascular Dysfunction ancillary study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}